Coherus BioSciences Inc (CHRS) stock news · rev $26.6M
Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
This CHRS news page leads with what Coherus BioSciences Inc filed — not a scraped headline mill.
No cached 8-K sentence for CHRS yet. We will not pad this page with generic market recap.
Latest reported CHRS revenue for 2026-06-30 was $26.6M. Net income was -$59.0M. CHRS currently screens at market cap $223.7M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CHRS stock page; for the tape open the quote page.
Not investment advice.